• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Industry
    • Exhibits and Support & Visibility Opportunities
    • Industry Archives
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2025 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2025 Proffered Presentations

2025 Proffered Presentations

 

← Back to Previous Page

 

S092: SELECTIVE VESTIBULAR NEURECTOMY FOR REFRACTORY MENIERE'S DISEASE: OUR EXPERIENCE WITH THE PRESIGMOID RETROLABYRINTHINE APPROACH
Fabio Greco1; Denis Aiudi2; Maurizio Gladi2; Alessio Iacoangeli2; Claudio Tortosa1; Francesca Bonifacio1; Fabrizio Salvinelli1; Maurizio Iacoangeli2; 1Policlinico Campus Bio-Medico di Roma; 2Università Politecnica delle Marche

Background: Refractory Meniere’s disease (MD) is a disabling disease; moreover, selective vestibular neurectomy (VN), in these selected cases of drug-resistant pathology, can be considered an alternative surgical option in order to preserve hearing and facial nerve function.

Methods: We retrospectively studied 30 patients with refractory MD diagnosis; an additional inclusion criteria was the failure of extradural endolymphatic sac surgery (ELSS). All patients underwent combined micro-endoscopic selective VN, between January 2019 and May 2024, via a presigmoid retrolabyrinthine approach and were classified according to clinical features and assessed pre and postoperative hearing and quality of life. 

Results: 90% vertigo control after surgery  was obtained with a maximum present follow-up of 2 years; a low rate of complications around 1-2% was registred.

No definitive facial palsy or hearing loss was described in this series and two patients required reintervention for a CSF fistula. Statistically significant (p = 0.001) difference was found between the preoperative and the postoperative performance in terms of physical, functional, and emotive scales assessed via the DHI questionnaire. 

Conclusions: Intractable vertigo associated with MD is potentially safely eligble for selective VN via a presigmoid retrolabyrinthine approach; residual hearing function should be verified pre-operatively. A tailored use of the endoscope and intraoperative neuromonitoring guaranteed the preservation of the cochlear and facial fibers with an overall precise result. As a multidisciplinary team we believe that this approach for VN combines the expertise of the otolaryngologist and the neurosurgeon in terms of lateral skull base anatomy and handling its related disorders; thus, in our opinion, best results are obtained together.

 

← Back to Previous Page

Copyright © 2025 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved